These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6846653)

  • 1. Depression, borderline disorder, and the DST.
    Am J Psychiatry; 1983 Jun; 140(6):818-20. PubMed ID: 6846653
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder.
    Baxter L; Edell W; Gerner R; Fairbanks L; Gwirtsman H
    J Clin Psychiatry; 1984 Apr; 45(4):150-3. PubMed ID: 6715286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in borderline personality disorder.
    Krishnan KR; Davidson JR; Rayasam K; Shope F
    Biol Psychiatry; 1984 Jul; 19(7):1149-53. PubMed ID: 6477995
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroendocrine evaluation of depression in borderline patients.
    Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
    Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterizing depression in borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM
    J Clin Psychiatry; 1987 Apr; 48(4):155-7. PubMed ID: 3558327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DST and Axis I diagnoses in borderline personality.
    Pitts FN
    J Clin Psychiatry; 1984 Apr; 45(4):149. PubMed ID: 6715285
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinguishing subtypes within the borderline domain: a combined psychoneuroendocrine approach.
    Steiner M; Martin S; Wallace JE; Goldman S
    Biol Psychiatry; 1984 Jun; 19(6):907-11. PubMed ID: 6743724
    [No Abstract]   [Full Text] [Related]  

  • 8. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Borderline pathology in hospitalized personality disorders].
    Modestin J; Toffler G
    Nervenarzt; 1985 Dec; 56(12):673-81. PubMed ID: 4094631
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying the depressive border of the borderline personality disorder.
    Snyder S; Sajadi C; Pitts WM; Goodpaster WA
    Am J Psychiatry; 1982 Jun; 139(6):814-7. PubMed ID: 7081498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression.
    Smith DJ; Muir WJ; Blackwood DH
    J Affect Disord; 2005 Jul; 87(1):17-23. PubMed ID: 15967232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcissistic, antisocial, and noncomorbid subgroups of borderline disorder. Are they distinct entities by long-term clinical profile?
    McGlashan TH; Heinssen RK
    Psychiatr Clin North Am; 1989 Sep; 12(3):653-70. PubMed ID: 2798201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of depression in borderline personality disorder and the diagnostic process.
    Silk KR
    J Pers Disord; 2010 Feb; 24(1):25-37. PubMed ID: 20205497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relations between borderline states and dysthymic disorders].
    Robert P; Benoit M
    Encephale; 1992 Dec; 18 Spec No 5():727-30. PubMed ID: 1342673
    [No Abstract]   [Full Text] [Related]  

  • 15. The dexamethasone suppression test in patients with borderline personality disorders.
    Soloff PH; George A; Nathan RS
    Am J Psychiatry; 1982 Dec; 139(12):1621-3. PubMed ID: 7149068
    [No Abstract]   [Full Text] [Related]  

  • 16. Stability and distinctness of borderline personality disorder.
    Barasch A; Frances A; Hurt S; Clarkin J; Cohen S
    Am J Psychiatry; 1985 Dec; 142(12):1484-6. PubMed ID: 4073317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Borderline syndrome: borderline area or no-man's land? On the clinico-psychiatric relevance of borderline diagnoses].
    Sass H; Koehler K
    Nervenarzt; 1983 May; 54(5):221-30. PubMed ID: 6866165
    [No Abstract]   [Full Text] [Related]  

  • 18. [New diagnostic and neuroendocrine approaches to the borderline syndrome].
    Castro P; Pardoen D; Toscano-Aguilar M; Mendlewicz J
    Encephale; 1986; 12(1):27-30. PubMed ID: 3698888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in borderlines: is it useful?
    Korzekwa M; Steiner M; Links P; Eppel A
    Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical psychiatry conference: biological and family indicators in depression.
    Baer RK; Muecke MM; Nasr S; Lahmeyer HW; Gaviria FM; Dysken MW; Akiskal HS; Dilsaver SC; Greden JF
    J Clin Psychiatry; 1983 Oct; 44(10):372-8. PubMed ID: 6417114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.